On December 4, 2024, Jason Rose spoke on a panel, “Managing Multidistrict Litigation: How Proposed Rule 16.1 Could Transform Early MDL Management,” at the Venable-Sponsored 29th Annual Conference on Drug and Medical Device Litigation, hosted by the American Conference Institute (ACI) in New York City. In this session, panelists explored the proposed rule’s impact and implications for procedures.